You have no items in your shopping cart.
Featured
Description
Research Area
Product Categories/Products/Proteins,Response to hypoxia,VEGF,Angiogenic growth factors,VEGF,Angiogenesis and vasculogenesis,Angiogenic factors ELISA kits,Growth factors and hormones ELISA kits,Co-factors,Hypoxia,Cancer,SARS Coronavirus,VEGF
Images & Validation
−Item 1 of 1
| Application Notes |
|---|
Key Properties
−| Expression System | E.coli |
|---|---|
| Target | Vascular endothelial growth factor A |
| Tag | C-His |
| Endotoxins | Not analyzed |
| MW | 20 kDa |
| Purity | > 95% as determined by SDS-PAGE |
| Protein Sequence | 27-191/191 |
Storage & Handling
−| Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
|---|---|
| Concentration | > 0.5 mg/ml |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−VEGF 165; Recombinant VEGF 165A; Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; Vegf; VEGFA; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF; VEGF A Precursor; Recombinant human VEGF-165 protein, C-His
Similar Products
−
Recombinant Human VEGFA Protein, C-His [orb1088542]
CLIA, EIA, LF
> 90% as determined by SDS-PAGE
20.8 kDa
HEK293
1 mgVEGF121 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960084]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF121 Protein, Human, Recombinant (His & Avi) [orb1960085]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF165 Protein, Human, Recombinant (His & Avi) [orb1960086]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-35 kDa under reduced (R) condition, 45-60 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 100 μg, 500 μgVEGF165 Protein, Human, Recombinant (His & Avi), FITC-Labeled [orb1960087]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-33 kDa under reduced (R) condition, 45-55 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 500 μg, 100 μg
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
Quick Database Links
Gene Symbol
Vascular endothelial growth factor A
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Protein Handling and Storage Guide
Protein Handling Guide
Recombinant human VEGF165 protein, C-His (orb1516905)
- 0.0
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a ReviewAvailable Sizes
Select a size below
Usually dispatched within 5-10 working days